2020
DOI: 10.1111/jam.14629
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of wysR gene enhances wuyiencin production in ΔwysR3 mutant strain of Streptomyces albulus var. wuyiensis strain CK‐15

Abstract: Aim: The aim of the present work was to investigate the overexpression of the wysR gene in Streptomyces albulus var. wuyiensis strain CK-15 based on the DwysR3 mutant strain including the effect on morphological development, wuyiencin production and antibacterial activity. At the same time, we report a new rapid method for producing genetically engineered strains for industrial production of wuyiencin. Methods and Results: We developed a method to create a wysR overexpression strain based on the DwysR3 mutant … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“…CFA-L-Ile is an amino acid analogue, and the CFA-L-Ile gene cluster consists of two PKS genes ( cfa6 and cfa7 ), one acyl carrier protein (ACP) gene ( cfa1 ), two acyl coenzyme A ligase genes ( cfa5 and cfal ), one oxidoreductase gene ( scab79681 ), a cytochrome P450 monooxygenase gene ( sabc79691 ), two reductase genes ( cfa8 and sabc79721 ), a hydroxybutyryl coenzyme A dehydrogenase gene ( sabc79711 ), and two regulatory genes ( orf1 and cfaR , which encode a PAS-LuxR family protein) [ 14 ]. Wuyiencin is an aminoglycoside antibiotic [ 15 , 16 ] that was mainly studied in biocontrol. The gene cluster has only been partially sequenced and it contains PAS-LuxR gene wysR .…”
Section: Pas-luxr Family Regulatorsmentioning
confidence: 99%
See 1 more Smart Citation
“…CFA-L-Ile is an amino acid analogue, and the CFA-L-Ile gene cluster consists of two PKS genes ( cfa6 and cfa7 ), one acyl carrier protein (ACP) gene ( cfa1 ), two acyl coenzyme A ligase genes ( cfa5 and cfal ), one oxidoreductase gene ( scab79681 ), a cytochrome P450 monooxygenase gene ( sabc79691 ), two reductase genes ( cfa8 and sabc79721 ), a hydroxybutyryl coenzyme A dehydrogenase gene ( sabc79711 ), and two regulatory genes ( orf1 and cfaR , which encode a PAS-LuxR family protein) [ 14 ]. Wuyiencin is an aminoglycoside antibiotic [ 15 , 16 ] that was mainly studied in biocontrol. The gene cluster has only been partially sequenced and it contains PAS-LuxR gene wysR .…”
Section: Pas-luxr Family Regulatorsmentioning
confidence: 99%
“…The transcript levels of wysE (thioesterase), wysRI (LAL family regulator), and wysRIII (DeoR family regulator) were analyzed in the wuyiencin biosynthetic gene cluster, and the results show that the transcript levels of wysRIII and wysE are remarkably lower in wysR deletion strain than that in the wild-type strain, while the transcript levels of wysRI remarkably increased compared with wild-type strains [ 16 ]. In the wysR overexpressing strain, the transcript levels of wysRIII and wysE remarkably increased, whereas the transcript levels of wysRI are significantly reduced compared with the wild-type strain [ 15 ]. Therefore, WysR directly or indirectly regulates the expression of other potential regulatory genes such as wysRI and wysRIII to affect the transcription of early wuyiencin PKS genes and regulates wysE to affect the late biosynthetic enzymes in wuyiencin production [ 16 ].…”
Section: Regulation Of Related Product Biosynthesis By Pas-luxr Famil...mentioning
confidence: 99%
“…Wuyiencin was separated and purified by Sephadex G-25 and ODS column chromatography and semipreparative high-performance liquid chromatography. These procedures were performed according to the methods of Wei et al (2020).…”
Section: Fermentation and Purification Of Wuyiencinmentioning
confidence: 99%
“…In order to unravel the biosynthetic richness of Actinobacteria, multiple genetic engineering methods, e.g. induction of BGCs by co-expression of regulatory genes 7 , 8 , use of transcription factor decoys 9 , refactoring of the BGCs 10 , 11 or knockouts of the core genes of “constitutively” produced compounds 12 have been explored. Recently, broader attention has been brought to the development of heterologous expression hosts for the discovery and characterization of novel metabolites.…”
Section: Introductionmentioning
confidence: 99%